- IFN
interferon
- IκB
inhibitory protein of NFκB
- iNOS
inducible nitric oxide synthase
- LPS
lipopolysaccharide
- NO
nitric oxide
- PBMC
peripheral blood mononuclear cells
- RSV
resveratrol
Introduction
Red wine contains a plethora of bioactive compounds, including the so-called polyphenols. These include flavonols, such as myricetin, kaempferol and the predominant quercetin, the flavan-3-ol monomers catechin and epicatechin, the oligomeric and polymeric flavan-3-ols or proanthocyanidins, many anthocyanins and a variety of phenolic acids (gallic acid, caftaric acid, caffeic acid and p-coumaric acid), plus the stilbene resveratrol (RSV)(Reference Scalbert, Johnson and Saltmarsh1).
Once ingested dietary polyphenols are able to interact and influence the function of many biological systems in the host, even including intestinal and systemic immunity. As far as immune responsiveness is concerned, it relies on a very intricate functional network between antigen presenting cells (macrophages and dendritic cells) and T helper-1, -2, -17 and T regulatory cells, which ultimately leads to immunity or tolerance(Reference Clark, Angel and Kato2–Reference Lombardi, Van Overtvelt and Joriot13). Furthermore, macrophages, dendritic cells and non-immune cells (endothelial and smooth muscle cells) bear, on their membrane, Toll-like receptors implicated in the activation of the pro-inflammatory pathway when triggered by exogenous or endogenous stimuli(Reference Medzhitov, Preston-Hurlburt and Janeway14–Reference Michelsen, Wong and Shah29). Any alteration of this delicate balance may account for disease outcome, even including age-related diseases, characterized by a low-grade inflammation(Reference Candore, Caruso and Jirillo30).
On these grounds, the aim of this review was to clarify the main mechanisms involved in the immunomodulating ability of polyphenols (flavonoids and RSV) in health and disease.
Polyphenols
Alcohol consumption has controversial effects on human health. There is evidence that chronic alcohol abuse leads to cancer development (e.g. carcinoma of the liver and pancreas), damage to the brain(Reference Nyirenda, O'Brien and Sanvito31) and impaired function of the immune system. On the other hand, according to epidemiological studies, it appears that light to moderate consumption of alcohol may reduce mortality. In particular, red wine consumption reduces CVD risk(Reference Harper32) and the protective effect is attained with two glasses of wine per day(Reference Gronbaek33). These effects are greater for red wine compared with white wine, beer, and most spirits where the amount of polyphenols is negligible(Reference Harper32). In particular, polyphenols are absent from white wine because the skins, seeds and stems are present during the fermentation of red wine only, which is one of the richest sources of polyphenols in the human diet.
The potential association between red wine consumption and risk of CVD mortality has been highlighted by the ‘French Paradox’(Reference Rotondo, Di Castelnuovo and de Gaetano34), which refers to the finding that people in France suffer from a relatively low incidence of coronary heart disease, despite their diet being rich in saturated fats.
The effects of flavonoids and RSV on human health will be discussed below.
Flavonoids
Flavonoids have been the object of intensive investigation for a number of reasons: (i) Based on their abundance in fruits and vegetables, these substances may explain some of the health-promoting effects of these foodstuffs; (ii) some foods are particularly rich in flavonoids, such as red wine, tea, onions, apples or dark chocolate, whose favorable cardiovascular effects are well known; (iii) medicinal plants rich in flavonoids or their extracts (e.g. an extract of Ginkgo biloba leaves) are used within alternative as well as academic medicine; (iv) specific flavonoids (e.g. quercetin) are also available in certain countries as nutraceuticals(Reference Ferrires35).
As far as the effects of flavonoids on the immune system are concerned, primary macrophages have been studied as potential cellular targets of these substances(Reference Perez-Vizcaino, Duarte and Jimenez36). A number of flavonoids inhibit macrophage proliferation (but not cell viability) and some additionally reduce TNFα and inducible nitric oxide synthase (iNOS) expression, probably by interfering with the NF-κB pathway. The structural determinants of activity include the C2–C3 double bond, the catechol group in the B ring and the 2-position of the B ring. Most of these flavonoids are glycosides, which are known to be hydrolyzed by bacterial enzymes in the gut. Since luteolin and quercetin are not active in vivo and aglycone flavonoids are absorbed in the small intestine, it is likely that glycosides act as prodrugs, releasing the biologically active aglycone in the lumen and preventing their premature absorption, which has been proven in the case of quercetin(Reference Comalada, Ballester and Bailon37).
Over recent years, our group has contributed to the knowledge of flavonoid mechanisms of action in an in vitro model using healthy human peripheral blood mononuclear cells (PBMC). In preliminary studies, three different types of Italian red wine (Primitivo, Lambrusco and Negroamaro) were screened for modulating nitric oxide (NO) production from monocytes. The effects of flavonoids were evaluated in an indirect manner by using wine samples that have previously been deprived of these substances. NO production was maximally obtained in the presence of Negroamaro and this datum was also confirmed by iNOS expression, as assessed by Western blot. In flavonoid-deprived samples, both activities (NO release and iNOS expression) were present at negligible levels. The same was true in samples containing only ethanol(Reference Comalada, Camuesco and Sierra38). The evidence that Negroamaro is the strongest inducer of NO seems to suggest a different composition of the polyphenols present in this wine, as also reported in other studies(Reference Magrone, Tafaro and Jirillo39, Reference Vogel40), which have related the different vasodilating ability of red wine to the type of grape and country of origin. The above results represent the first evidence of the ability of red wine to generate NO from human monocytes, despite previous reports about the endothelial origin of NO as a regulator of vascular homeostasis(Reference Wallerath, Poleo and Li41). According to our working hypothesis(Reference Balzer, Heiss and Schroeter42), in response to acute consumption of flavonoids in red wine, gut-associated macrophages can generate NO that, in turn, reaches the blood via the lymphatic route. As an alternative, flavonoids that are absorbed at the intestinal level and released into the circulation are able to stimulate monocytes to produce NO. In fact, there is evidence that in healthy volunteers, anthocyanins from red grape juice are absorbed at the intestinal level(Reference Magrone, Candore and Caruso43). In synthesis, it appears that moderate intake of red wine via NO release can prevent atherogenesis by virtue of its vasodilatory capacities(Reference Comalada, Camuesco and Sierra38). As far as release of cytokines from PBMC stimulated with Negroamaro is concerned, this wine was able to skew the immune response toward the T helper-1 cell type via the release of IL-12 and consequentially of interferon (IFN)-γ(Reference Bitsch, Netzel and Frank44). Furthermore, production of IL-1β and IL-6 occurred, thus suggesting a switch toward the inflammatory pathway. On the other hand, release of the anti-inflammatory cytokine IL-10 was also triggered by Negroamaro, thus indicating that the production of IL-6 and IL-1β was still under the control of IL-10(Reference Magrone, Tafaro and Jirillo45). In turn, IL-6 stimulates IL-10 production, generating a local feedback loop in order to limit the pro-inflammatory pathway(Reference Couper, Blount and Riley46). This event accounts for the maintenance of the inflammatory:anti-inflammatory ratio.
As far as B cell responses are concerned, in our test system flavonoids favoured the production of both IgA (mucosal response) and IgG (systemic response). In particular, at the gut-associated lymphoid tissue level, one can speculate that flavonoid-activated B cells may migrate to distant organs, such as the spleen and the secretory glands in the body(Reference Balzer, Heiss and Schroeter42), thus representing an amplification loop of the immune response. These immunological mechanisms are able to protect the host against pathogens as well as against neoplastic events via cytotoxic T cell and natural killer cell activation(Reference Steensberg, Fisher and Keller47, Reference Brien, Uhrlaub and Nikolich-Zugich48). Based on these concepts, moderate red wine assumption might be useful to consider in age-related disorders because it is known that immunosenescence is characterized by a status of dysregulated immunity that leads to the increased susceptibility of the elderly to infections and autoimmune disease(Reference Newman and Riley49, Reference Hayflick50). In this framework, it is worth mentioning that macrophages from old individuals produce much less hydrogen peroxide and NO than young individuals(Reference Candore, Colonna-Romano and Balistrieri51). Interestingly, it has been reported that aged mice express less total p38 and C-Jun N-terminal kinase(Reference Pawelec, Solana and Remarque52) and, at the same time, an elevation of p38 and extracellular regulated kinase in red-wine-treated PBMC was observed(Reference Bohemer, Goral and Faunce53). Therefore, the increased expression of p38 by flavonoids(Reference Magrone, Panaro and Jirillo54) may trigger the induction of the IFN-γ pathway, increase the release of pro-inflammatory cytokines and promote Ig class switch in B cells, since p38 is a common denominator for all these pathways(Reference Merritt, Enslen and Diehl55). In conclusion, moderate red wine consumption or intake of flavonoids can be advantageous in the elderly via increased production of NO by macrophages and p38-induced IFN-γ release.
In our experiments, we found that the expression of phosphorylated p38 was enhanced by lipopolysaccharide (LPS) alone, while in samples simultaneously stimulated with LPS and Negroamaro, a decreased expression of activated p38 was observed. This may indicate that flavonoids tend to down-regulate the LPS-induced p38 phosphorylation pathway(Reference Balzer, Heiss and Schroeter42). Furthermore, this fact may be beneficial in the course of Gram-negative infections, where inhibition of p38α activity by the inhibitor SB203580 reduced mortality related to LPS-dependent shock and occurrence of collagen-induced arthritis(Reference Cook, Wu and Kang56, Reference Pietersma, Tilly and Gaestel57). These findings have recently been confirmed by the demonstration that macrophage deletion of p38α mitigates noxious effects triggered by LPS(Reference Badger, Bradbeer and Votta58).
Interestingly, p38 per se may be responsible for NO release and iNOS expression, probably through another nuclear factor, such as signal transducer and activator of transcription-1 (Stat-1) or activator protein-1. In other experiments, we reported an elevated production of IFN-γ by monocytes treated with flavonoids(Reference Bitsch, Netzel and Frank44). In this context, IFN-γ could act together with p38 as an activation signal of Stat-1(Reference Kang, Chen and Otsuka59, Reference Ganster, Taylor and Shao60) that, in turn, by binding to motifs at −5·2 and −5·8 kb in the iNOS promoter, might determine iNOS expression and, therefore, NO synthesis.
The NF-κB family of transcription factors consists of five members of the mammalian NF-κB family: p50/p105, p52/p100, p65, c-Rel and RelB, which are kept inactive in the cytoplasm by association with inhibitors (I)κB proteins(Reference Guo, Shao and Du61) identified as IκBα, IκBβ and IκBε. They maintain NF-κB dimers in the cytoplasm and are crucial to signal responsiveness. IκBα is rapidly degraded during activation, of canonical NF-κB signalling pathways, leading to the release of multiple NF-κB dimers. Binding to IκBα prevents the translocation of NF-κB into the nucleus, thereby maintaining NF-κB in an inactive state. In response to an inflammatory stimulus, cytokines or viral infections, IκB proteins are rapidly degraded by the multicatalytic proteasome(Reference Ghosh, May and Kopp62). IκBα has the capacity to both prevent NF-κB binding and dissociate NF-κB from specific DNA consensus sequences. Nuclear localization of IκBα is induced by stimuli activating NF-κB and can be considered as part of a physiological mechanism regulating NF-κB-dependent transcription(Reference Renard, Percherancier and Kroll63).
The main observation related to IκBα is that this factor enters the nucleus steadily in cells continuously exposed to stimulation, but is constantly degraded in the nuclear compartment as long as stimulation persists(Reference Renard, Percherancier and Kroll63). In our previous study(Reference Bohemer, Goral and Faunce53), the phosphorylated form of IκBα was expressed at lower levels in PBMC treated with Negroamaro compared with the unphosphorylated form. However, there is evidence that more molecules of IκBα are generated with time and, therefore, this molecule participates in a feedback loop, where newly synthesized IκBα inhibits the activity of NF-κB(Reference Turpin, Hay and Dargemont64). These data suggest that flavonoids switch off the NF-κB pathway, thus reducing the release of pro-inflammatory cytokines (e.g. IL-1β).
In another series of results obtained by immunofluorescence analysis, we demonstrated that cells underwent a marked expression of p65 after treatment with whole wine and flavonoids alone, although this was lower than that observed with LPS-treated PBMC(Reference Bohemer, Goral and Faunce53). This finding reinforces the concept of the beneficial effects of flavonoids on human health, since an excessive production of p65/NF-κB would lead to induction of several genes that ultimately generate noxious effects into the host(Reference Bohemer, Goral and Faunce53). In conclusion, molecular mechanisms elicited by flavonoids on human PBMC seem to play a beneficial role in the host. One can postulate that NO release following activation of extracellular regulated kinase and p38 kinase is able to inhibit platelet aggregation, thus reducing the influx of atherogenic monocytes and LDL through endothelial cells into the wall of arteries and ultimately limiting atherogenesis. Furthermore, NO production may reduce infectious events, such as Chlamydia pneumoniae infection, which represents an important etiological factor in atherosclerosis(Reference Hayden and Ghosh65, Reference Sawayama, Tatsukawa and Maeda66).
As far as the role of LPS in atherogenesis is concerned, inhibition of phosphorylated p38 expression in the presence of LPS, as well as the regulatory role of Iκβα mediated by flavonoids, should be taken into consideration in the arrest of the proinflammatory cytokine pathway in a variety of diseases.
In Table 1, the major effects of flavonoids from Negroamaro wine are listed.
NO, nitric oxide, NOS, inducible NO synthase; ERK, extracellular regulated kinase.
Resveratrol
RSV (3,4′,5-trihydroxystilbene) is contained in the skins of red fruits, such as mulberries and red grapes(Reference Watson and Alp67, Reference Holme and Pervaiz68), and therefore its intake occurs along with flavonoids.
Over recent years, increasing interest in RSV from red wine in relation to human health has been reported. In fact, RSV prevents or delays the onset of age-related diseases, such as diabetes, inflammation, Alzheimer's disease and CVD, also inducing neuroprotection and inhibiting neoplastic growth(Reference Pervaiz69–Reference Vidavalur, Otani and Singal77). The therapeutic potential of RSV has been demonstrated by the extended lifespan and ameliorated motor function in mice fed a high-energy diet(Reference Aggarwal, Bhardwaj and Aggarwal78). The potential benefits to human health include the full range of CVD-associated conditions, e.g. myocardial infarction, arrhythmias, hypertension, hypertrophy, inflammation leading to fibrosis, atherosclerosis and thrombosis.
Although RSV acts as an antioxidant, primarily by increasing NO bioavailability, it can also exhibit pro-oxidant properties in the presence of transition metal ions such as Cu, thus leading to oxidative breakage of cellular DNA(Reference Baur, Pearson and Price79), which seems to be the common denominator for anticancer and chemopreventive properties of the polyphenol family(Reference Alarco´n de la Lastra and Villegas80). In fact, plant polyphenols are able to modulate the effects of deregulated cell cycle checkpoints, as a basis for cancer chemoprevention(Reference Khan, Afaq and Mukhtar81).
Low-grade inflammation is implicated in various diseases such as the metabolic syndrome(Reference Meeran and Katiyar82), rheumatoid arthritis and neurodegenerative disorders(Reference Dandona, Aljada and Chaudhuri83). The cardioprotection and cancer prevention of RSV may depend on its anti-inflammatory effects, such as the inhibition of synthesis and release of pro-inflammatory cytokines and of eicosanoids and the inhibition of immune cell activation. Enzyme inhibition of cyclooxygenase-1 or cyclooxygenase-2 by the inhibitory effects of RSV on transcription factors such as NF-κB or activator protein-1 has also been reported(Reference Stolp and Dziegielewska84, Reference Das and Das85). Furthermore, RSV associated with moderate wine intake activates platelet endothelial NOS and, in this way, blunts the pro-inflammatory pathway linked to p38 mitogen-activated protein kinase, thus inhibiting reactive oxygen species production and ultimately platelet function. In another study, RSV(Reference Udenigwe, Ramprasath and Aluko86) was able to reduce oxidative burst, chemotaxis and degranulation in human neutrophils as well as pro-inflammatory cytokines, such as IL-6, IL-1β, TNF-α and chemokine macrophage inflammatory protein-1α in vitro, as well as in a murine model of acute peritonitis. In this regard, two important targets of RSV were identified, namely the lipid mediator phospholipase D and the proinflammatory kinase SphK.
Other effects of RSV are listed in Table 2.
Conclusion and future perspective
Current nutritional approaches to prevent inflammatory, metabolic, neoplastic and aged related-diseases are a major strategy for the improvement of human health and longevity(Reference Kiziltepe, Turan and Han94).
In this review, data from the current literature and our own data demonstrate the ability of red wine to modulate the immune response by virtue of its flavonoid content and RSV. As a result, low-grade inflammation, which is a common denominator of several diseases, can be prevented or mitigated. In fact, in terms of clinical applications, other diseases besides atherosclerosis can be prevented by wine consumption. For instance, in the Bordeaux region, a negative correlation was found between moderate wine intake and Alzheimer's disease. Furthermore, in the third Copenhagen City Heart Study on aged people, monthly and weekly consumption of wine was associated with a lower risk of dementia(Reference Jirillo, Candore and Magrone95). In a previous study, based on a cohort of 1367 subjects with dementia, flavonoid ingestion was inversely correlated to the risk of dementia(Reference Truelsen, Thudium and Gronbaek96). In another study, a protective effect of wine consumption on age-related macular degeneration compared to non-drinkers was reported(Reference Mukamal, Kuller and Fitzpatrick97, Reference Sharma, Mishra and Ghosh98).
In conclusion, polyphenols from red grape could be considered along with other dietary substances such as pre/probiotics and oligoelements (e.g. Zn and Se) as potentiators of the immune response.
Acknowledgements
This paper was supported by the Ministry of University Research and the Ministry of Health (Rome, Italy). T. M. contributed to the experimental design and technical part of the experiments described in this review. E. J. contributed to the experimental design of the experiments described in this review. The authors have no conflict of interest.